166 related articles for article (PubMed ID: 38159338)
1. Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study.
Dubov A; Basenko A; Dymaretskyi O; Shoptaw S
Drug Alcohol Depend; 2024 Feb; 255():111069. PubMed ID: 38159338
[TBL] [Abstract][Full Text] [Related]
2. Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?
Dellamura P; Meteliuk A; Fomenko T; Rozanova J
Front Public Health; 2023; 11():1259488. PubMed ID: 38239802
[TBL] [Abstract][Full Text] [Related]
3. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
[TBL] [Abstract][Full Text] [Related]
4. The impact of the 2014 military conflict in the east of Ukraine and the Autonomous Republic of the Crimea among patients receiving opioid agonist therapies.
Meteliuk A; Sazonova Y; Goldmann E; Xu S; Liutyi V; Liakh T; Spirina T; Lekholetova M; Islam Z; Ompad DC
J Subst Use Addict Treat; 2024 May; 160():209312. PubMed ID: 38336264
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
[TBL] [Abstract][Full Text] [Related]
7. Responding to health policy recommendations on managing opioid use disorder during Russia's invasion of Ukraine: Divergent responses from the frontline to the west.
Ivasiy R; Galvez de Leon SJ; Meteliuk A; Fomenko T; Pykalo I; Bromberg DJ; Madden LM; Farnum SO; Islam Z; Altice FL
Front Public Health; 2022; 10():1044677. PubMed ID: 36711398
[No Abstract] [Full Text] [Related]
8. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
Bandara S; Kennedy-Hendricks A; Merritt S; Barry CL; Saloner B
Addiction; 2021 Dec; 116(12):3473-3481. PubMed ID: 33999458
[TBL] [Abstract][Full Text] [Related]
9. Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Pykalo I; Madden L; Filippovich S; Dvoriak S; Altice FL
J Subst Abuse Treat; 2018 Apr; 87():1-8. PubMed ID: 29471921
[TBL] [Abstract][Full Text] [Related]
10. Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions.
Salamanca-Buentello F; Cheng DK; Sabioni P; Majid U; Upshur R; Sud A
Int J Drug Policy; 2022 Mar; 101():103556. PubMed ID: 34902805
[TBL] [Abstract][Full Text] [Related]
11. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
[TBL] [Abstract][Full Text] [Related]
13. Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.
Zelenev A; Shea P; Mazhnaya A; Rozanova J; Madden L; Marcus R; Altice FL
Drug Alcohol Depend; 2018 Sep; 190():82-88. PubMed ID: 29990648
[TBL] [Abstract][Full Text] [Related]
14. Treatment of opioid use disorder in Ukraine during the first year of the Russia-Ukraine war: Lessons learned from the crisis.
Morozova O; Ivanchuk I; Gvozdetska O; Nesterova O; Skala P; Kuzin I; Dumchev K
Int J Drug Policy; 2023 Jul; 117():104062. PubMed ID: 37216758
[TBL] [Abstract][Full Text] [Related]
15. Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia's invasion of Ukraine in five major cities in Ukraine.
Mazhnaya A; Meteliuk A; Pykalo I; Altice FL
Front Public Health; 2023; 11():1238188. PubMed ID: 38162610
[TBL] [Abstract][Full Text] [Related]
16. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
[TBL] [Abstract][Full Text] [Related]
17. Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosing.
Corace K; Suschinsky K; Wyman J; Leece P; Cragg S; Konefal S; Pana P; Barrass S; Porath A; Hutton B
Int J Drug Policy; 2022 Apr; 102():103573. PubMed ID: 35123246
[TBL] [Abstract][Full Text] [Related]
18. Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
Madden L; Bojko MJ; Farnum S; Mazhnaya A; Fomenko T; Marcus R; Barry D; Ivanchuk I; Kolomiets V; Filippovych S; Dvoryak S; Altice FL
Int J Drug Policy; 2017 Nov; 49():48-53. PubMed ID: 28957756
[TBL] [Abstract][Full Text] [Related]
19. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.
Russell C; Nafeh F; Pang M; MacDonald SF; Derkzen D; Rehm J; Fischer B
BMC Public Health; 2022 Mar; 22(1):436. PubMed ID: 35246083
[TBL] [Abstract][Full Text] [Related]
20. Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.
Conway A; Marshall AD; Crawford S; Hayllar J; Grebely J; Treloar C
Implement Sci; 2023 Jun; 18(1):22. PubMed ID: 37296448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]